Physician profile
Ryan D Dickerson
NPI 1912921784
$4,378.09
in general payments reported to CMS, 2019-2025
26 companies · $1,452 in 2025
The $1,452 reported for 2025 was more than what 93% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $271 · 2020: $265 · 2021: $130 · 2022: $537 · 2023: $1,066 · 2024: $656 · 2025: $1,452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,178 · Consulting Fee: $700 · Travel and Lodging: $296.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,178.22 |
| Consulting Fee | $700.00 |
| Travel and Lodging | $296.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,348.30 | 2025 | |
| Acessa Health INC. | $790.95 | 2019-2023 | Acessa Provu System |
| Gynesonics, INC. | $773.30 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Abbvie INC. | $417.62 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Caldera Medical, INC | $175.34 | 2024 | Desara |
| Hologic Sales and Service, LLC | $118.98 | 2019-2024 | Myosure Tissue Removal Device, Acessa Provu System, Novasure |
| Channel Medsystems, INC. | $99.74 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $98.04 | 2021-2025 | |
| Amgen INC. | $91.82 | 2019-2020 | |
| Pfizer INC. | $73.11 | 2022-2024 | |
| Astellas Pharma US INC | $54.53 | 2023-2025 | Veozah |
| Smith+Nephew, INC. | $40.26 | 2022-2023 | Grafix Pl, Stravix Pl |
| Organon LLC | $37.02 | 2022-2024 | |
| Sumitomo Pharma America, INC. | $33.53 | 2024 | Myfembree |
| Renovia INC | $32.20 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $30.41 | 2020 | |
| Therapeuticsmd, INC. | $24.66 | 2022 | |
| Meditrina | $22.35 | 2025 | |
| Integra Lifesciences Corporation | $18.54 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Agile Therapeutics, INC. | $16.74 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $14.81 | 2020 | |
| Lupin INC. | $13.88 | 2020 | |
| Coopersurgical, INC. | $13.46 | 2021 | |
| Avion Pharmaceuticals | $13.19 | 2019 | |
| Exeltis, USA INC. | $12.70 | 2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $12.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Dickerson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.